Amgen Inc to acquire Horizon Therapeutics
The board of directors of Horizon Therapeutics plc and the board of directors of Amgen Inc. are pleased to announce that they have reached agreement on the terms of a cash offer for the Company by Pillartree Limited, a newly formed private limited company wholly owned by Amgen, which is unanimously recommended by the Company Board and pursuant to which Pillartree will acquire the entire issued and to be issued ordinary share capital of the Company
Under the terms of the Acquisition, each Company Shareholder at the Scheme Record Time will be entitled to receive: $116.50 for each Company Share in cash
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
